Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced the appointment of. Mr. Sandoval’s appointment comes as Milestone launches CARDAMYST™ (etripamil) nasal spray, the first and only approved ...

ABU DHABI, 10th February, 2026 (WAM) -- Yas Clinic – Khalifa City, in partnership with Abu Dhabi Stem Cells Centre (ADSCC), continues to advance innovative pediatric cancer care through a complex bone ...

The State Council of the PRC promulgated the Implementing Regulations of the Drug Administration Law (2026 Revisions) on January 27, 2026, set to ...

Ingelise Saunders, Chair of BOOST Pharma, said: “Hans’ transition to CEO comes at a pivotal time for the company. With his ...

Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 ...

Iterion Therapeutics, a clinical-stage, biopharmaceutical company dedicated to revolutionizing the treatment of Wnt-driven ...

Pre-submission package is a process that facilitates early feedback from the United Kingdom (UK) Medicines and Healthcare Products Regulatory ...

THX Pharma (Theranexus) and Biocodex, an independent international pharmaceutical group, today announced the execution of a strategic licensing agreement to advance the development of two drug ...

Q4 2025 Earnings Call February 10, 2026 8:00 AM ESTCompany ParticipantsAlexis Smith - Vice President & Head of ...

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced the appointment of David Sandoval as General Counsel and Chief Compliance ...

Vestar, a leading privately held shopping center owner and operator in the United States, closed a milestone year in 2025 marked by portfolio-wide growth and continued momentum across leasing, ...

ClearFlow has announced that its PleuraFlow Active Clearance Technology (ACT) has received an Innovative Technology contract from Vizient, the nation’s largest provider-driven healthcare performance ...